Pfizer Patents – Insights & Stats (Updated 2025)

Pfizer has a total of 77363 patents globally, out of which 22686 have been granted. Of these 77363 patents, more than 29% patents are active. United States of America is where Pfizer has filed the maximum number of patents, followed by Japan and Europe (EPO). Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Pfizer.

Pfizer was founded in the year 1849. The company operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas.

Do read about some of the most popular patents of Pfizer which have been covered by us in this article and also you can find Pfizer patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Pfizer patent portfolio.

How many patents does Pfizer have?

Pfizer has a total of 77363 patents globally. These patents belong to 13243 unique patent families. Out of 77363 patents, 22351 patents are active.

How Many Patents did Pfizer File Every Year?

Pfizer Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantPfizer Applications FiledPfizer Patents Granted
202525186
2024376706
2023805920
20221056868
20211694995
202013541073
20191907994
201820481012
201721221042
20162405874

Which Pfizer Drug Patents are Expiring in the Next 10 Years?

The patent no. US8420650B2 which is expiring in Jul, 2029, describes changing in poly(ADP-ribose)polymerase (PARP) activity to treat or prevent diseases related to PARP. This involves giving a subject a therapeutic amount of compounds represented by Formula (I) and Formula (II), along with ionizing radiation, chemotherapy, or both.

Given below is the list of few drugs patented by Pfizer accompanied by a patent relevant to the drug which will be available for generic drug manufacturing and usage within the next/upcoming 10 years for treatment of various diseases and disorders.

Drug NamePatent NumberPatent TitlePatent Expiration
TalzennaUS8420650B2Dihydropyridophthalazinone Inhibitors…Jul, 2029
ToviazUS7807715B2Pharmaceutical Compositions Compr…Jun, 2027
VizimproUS10596162B2Method For Treating Gefitinib…Feb, 2026
VyndaqelUS7214696B2Compositions And Methods For…Dec, 2024
Nurtec OdtUS11083724B2Rimegepant For CGRP Related Dis…Mar, 2039

How many Pfizer patents are Alive/Dead?

Pfizer Patent Portfolio

How Many Patents did Pfizer File in Different Countries?

Pfizer Worldwide Patent Filing

Countries in which Pfizer Filed Patents

CountryPatents
United States Of America6548
Japan5180
Europe (EPO)4618
Mexico3224
China2896
Australia2765
India2738
Canada2597
Brazil2551
Hong Kong (S.A.R.)2447
Korea (South)2268
Taiwan1982
Israel1777
Singapore1769
Argentina1646
Spain1616
Germany1560
South Africa1518
Austria1478
New Zealand1071
Russia1022
Denmark996
Malaysia956
Indonesia954
Poland924
Chile903
Norway881
Portugal831
Tunisia736
Viet Nam718
Peru681
Slovenia639
Philippines608
Africa585
Costa Rica582
Eurasia526
Hungary456
Colombia456
Ecuador392
Saudi Arabia385
Uruguay357
Slovakia352
Ukraine342
Serbia327
Morocco324
Croatia312
Panama278
Estonia271
Cyprus268
Dominican Republic250
Mongolia246
Malta231
Georgia222
Thailand214
Netherlands208
Macao202
Turkey193
Cuba175
Italy156
El Salvador141
Iceland139
Uzbekistan139
Lithuania127
Nicaragua125
Yugoslavia/Serbia and Montenegro119
Czech Republic97
Gulf Cooperation Council96
Bulgaria92
Egypt91
Albania81
Finland79
Ireland78
Honduras70
Brunei64
Guatemala62
Republic Of Moldova61
Montenegro59
Pakistan59
Paraguay59
Bolivia57
United Kingdom41
Luxembourg39
Bangladesh33
Lebanon31
Kenya25
San Marino15
Romania14
Algeria13
France11
Former Yugoslav Republic of Macedonia11
Belgium10
United Arab Emirates10
Trinidad and Tobago9
Rwanda6
Jordan4
Switzerland3
Belize3
Kazakhstan2
Belarus2
Latvia2

Where are Research Centres of Pfizer Patents Located?

Pfizer R&D Centers

10 Best Pfizer Patents

US7144575B2 is the most popular patent in the Pfizer portfolio. It has received 1424 citations so far from companies like Ortho Pharmaceutical and Biocyte Corporation.

Below is the list of 10 most cited patents of Pfizer:

Publication NumberCitation Count
US7144575B21424
WO2011143545A11149
WO2012032433A1732
WO2005037214A2513
WO2007113648A2432
WO2010048314A1420
WO2005116014A1411
US20080234251A1394
WO2005009997A1392
WO2016092419A1342

What Percentage of Pfizer US Patent Applications were Granted?

Pfizer (Excluding its subsidiaries) has filed 5729 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2728 have been granted leading to a grant rate of 70.6%.

Below are the key stats of Apple patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Pfizer?

Law FirmTotal ApplicationsSuccess Rate
Pfizer (Inhouse IP Dept.)233664.92%
Gregg C Benson59021.47%
Peter C Richardson50494.47%
Paul H Ginsburg23886.66%
Charles J Knuth16887.20%
Haley Guiliano Llp12181.14%
Zoetis11187.27%
Scully Scott Murphy & Presser Pc8168.07%
Johnson & Johnson8071.43%

EXCLUSIVE INSIGHTS COMING SOON!

What are Pfizer’s key innovation segments?

What Technologies are Covered by Pfizer?

The chart below distributes patents filed by Pfizer in different countries on the basis of the technology protected in patents. It also represents the markets where Pfizer thinks it’s important to protect particular technology inventions.

R&D Focus: How Pfizer search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Pfizer?

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.